{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:38:55Z","timestamp":1790163535434,"version":"4.1.0"},"reference-count":64,"publisher":"Impact Journals, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,2,28]]},"DOI":"10.18632\/oncotarget.14741","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T18:55:01Z","timestamp":1484938501000},"page":"14912-14924","source":"Crossref","is-referenced-by-count":30,"title":["Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy"],"prefix":"10.18632","volume":"8","author":[{"given":"Hongfeng","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzane Ramos","family":"da Silva","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo C.T.","family":"Aguiar","sequence":"additional","affiliation":[{"name":"Department of Medicine and Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA"},{"name":"South Texas Veterans Health Care System, Audie Murphy VA Hospital, San Antonio, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Jiang","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,1,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1182\/blood-2014-05-577189","article-title":"Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity","volume":"125","author":"Gascoyne","year":"2015","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2015-01-623777","article-title":"A roadmap for discovery and translation in lymphoma","volume":"125","author":"Staudt","year":"2015","journal-title":"Blood"},{"key":"3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Pinkus","year":"2005","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Marti","year":"2000","journal-title":"Nature"},{"key":"5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/MOH.0b013e3283623d7f","article-title":"The genetic basis of diffuse large B-cell lymphoma","volume":"20","author":"Pasqualucci","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2174\/1389450111314060006","article-title":"Human sirtuins: an overview of an emerging drug target in age-related diseases and cancer","volume":"14","author":"Ponassi","year":"2013","journal-title":"Curr Drug Targets"},{"key":"7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.freeradbiomed.2012.10.525","article-title":"Seven sirtuins for seven deadly diseases of aging","volume":"56","author":"Morris","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"8","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrc3985","article-title":"The multifaceted functions of sirtuins in cancer","volume":"15","author":"Guarente","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1182\/blood-2011-06-361691","article-title":"Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"10","first-page":"589","article-title":"SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells","volume":"32","author":"Chen","year":"2012","journal-title":"Oncogene"},{"key":"11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","article-title":"Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib","volume":"21","author":"Bhatia","year":"2012","journal-title":"Cancer Cell"},{"key":"12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","article-title":"SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells","volume":"15","author":"Ha","year":"2014","journal-title":"Cell Stem Cell"},{"key":"13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12885-015-1282-1","article-title":"Tenovin-6-mediated inhibition of SIRT1\/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem\/progenitor cells","volume":"15","author":"Pan","year":"2015","journal-title":"BMC Cancer"},{"key":"14","doi-asserted-by":"publisher","first-page":"75698","DOI":"10.18632\/oncotarget.12359","article-title":"SIRT1-mediated downregulation of p27Kip1 is essential for overcoming contact inhibition of Kaposi","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"15","doi-asserted-by":"crossref","first-page":"e57633","DOI":"10.1371\/journal.pone.0057633","article-title":"Inhibition of the NAD-dependent protein deacetylase SIRT2 induces granulocytic differentiation in human leukemia cells","volume":"8","author":"Komatsu","year":"2013","journal-title":"PLoS One"},{"key":"16","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.bmc.2012.01.001","article-title":"Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins","volume":"20","author":"Westwood","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccr.2008.03.004","article-title":"Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator","volume":"13","author":"Holland","year":"2008","journal-title":"Cancer Cell"},{"key":"18","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/srep01275","article-title":"Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6","volume":"3","author":"Coates","year":"2013","journal-title":"Sci Rep"},{"key":"19","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1038\/bjc.2013.601","article-title":"p53 and cell cycle independent dysregulation of autophagy in chronic lymphocytic leukaemia","volume":"109","author":"Tauro","year":"2013","journal-title":"Br J Cancer"},{"key":"20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1182\/blood.V83.1.191.191","article-title":"Alterations of the p53 tumor suppressor gene in diffuse large cell lymphomas with translocations of the c-MYC and BCL-2 proto-oncogenes","volume":"83","author":"Berinstein","year":"1994","journal-title":"Blood"},{"key":"21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/1078-0432.CCR-13-3346","article-title":"Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma","volume":"21","author":"Zhang","year":"2015","journal-title":"Clin Cancer Res"},{"key":"22","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.18632\/oncotarget.2720","article-title":"Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma","volume":"6","author":"Zinzani","year":"2015","journal-title":"Oncotarget"},{"key":"23","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1080\/1042819021000032917","article-title":"A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma","volume":"43","author":"Enblad","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/leu.2011.28","article-title":"Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21)","volume":"25","author":"Medeiros","year":"2011","journal-title":"Leukemia"},{"key":"25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.molcel.2014.12.013","article-title":"Deacetylation of nuclear LC3 drives autophagy initiation under starvation","volume":"57","author":"Liu","year":"2015","journal-title":"Mol Cell"},{"key":"26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.freeradbiomed.2016.03.022","article-title":"A SIRT3\/AMPK\/autophagy network orchestrates the protective effects of trans-resveratrol in stressed peritoneal macrophages and RAW 264.7 macrophages","volume":"95","author":"He","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/BJ20130414","article-title":"Bioenergetic and autophagic control by Sirt3 in response to nutrient deprivation in mouse embryonic fibroblasts","volume":"454","author":"Zhang","year":"2013","journal-title":"Biochem J"},{"key":"28","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/15548627.2015.1052208","article-title":"SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin","volume":"11","author":"Lu","year":"2015","journal-title":"Autophagy"},{"key":"29","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/jcp.24399","article-title":"Sirtuins\u2019 modulation of autophagy","volume":"228","author":"Tang","year":"2013","journal-title":"J Cell Physiol"},{"key":"30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ceb.2009.12.001","article-title":"Autophagy regulation by p53","volume":"22","author":"Kroemer","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"31","doi-asserted-by":"crossref","first-page":"e1483","DOI":"10.1038\/cddis.2014.385","article-title":"SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth","volume":"5","author":"Brodin","year":"2014","journal-title":"Cell Death Dis"},{"key":"32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ncb1537","article-title":"The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis","volume":"9","author":"Mills","year":"2007","journal-title":"Nat Cell Biol"},{"key":"33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc776","article-title":"Death and anti-death: tumour resistance to apoptosis","volume":"2","author":"Krammer","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"34","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nature03029","article-title":"The role of autophagy during the early neonatal starvation period","volume":"432","author":"Mizushima","year":"2004","journal-title":"Nature"},{"key":"35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1083\/jcb.152.4.657","article-title":"Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells","volume":"152","author":"Yoshimori","year":"2001","journal-title":"J Cell Biol"},{"key":"36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"Ait-Si-Ali","year":"2012","journal-title":"Autophagy"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Yuan, Tan, Gao. Tenovin-6 impairs autophagy by inhibiting autophagic flux. Cell Death Dis. 2017. in press.","DOI":"10.1038\/s41419-018-0826-0"},{"key":"38","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1038\/ncomms8007","article-title":"Autophagosome-lysosome fusion is independent of V-ATPase-mediated acidification","volume":"6","author":"Neufeld","year":"2015","journal-title":"Nat Commun"},{"key":"39","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/cr.2013.11","article-title":"Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion","volume":"23","author":"Shen","year":"2013","journal-title":"Cell Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1172\/JCI33700","article-title":"Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis","volume":"118","author":"Kastan","year":"2008","journal-title":"J Clin Invest"},{"key":"41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.devcel.2004.07.009","article-title":"Role and regulation of starvation-induced autophagy in the Drosophila fat body","volume":"7","author":"Neufeld","year":"2004","journal-title":"Dev Cell"},{"key":"42","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2147\/OTT.S37750","article-title":"The emerging and diverse roles of sirtuins in cancer: a clinical perspective","volume":"6","author":"Chen","year":"2013","journal-title":"Onco Targets Ther"},{"key":"43","doi-asserted-by":"crossref","first-page":"e102831","DOI":"10.1371\/journal.pone.0102831","article-title":"Antitumor effects of a sirtuin inhibitor, tenovin-6, against gastric cancer cells via death receptor 5 up-regulation","volume":"9","author":"Hyodo","year":"2014","journal-title":"PLoS One"},{"key":"44","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1158\/0008-5472.CAN-14-1736","article-title":"Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma","volume":"74","author":"Berg","year":"2014","journal-title":"Cancer Res"},{"key":"45","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1158\/0008-5472.CAN-12-3359","article-title":"Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer","volume":"73","author":"Bouwens","year":"2013","journal-title":"Cancer Res"},{"key":"46","first-page":"155","article-title":"The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells","volume":"21","author":"Hyodo","year":"2013","journal-title":"Oncol Res"},{"key":"47","doi-asserted-by":"crossref","first-page":"22622","DOI":"10.1038\/srep22622","article-title":"Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma","volume":"6","author":"Pan","year":"2016","journal-title":"Sci Rep"},{"key":"48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nbt.3130","article-title":"Acetylation site specificities of lysine deacetylase inhibitors in human cells","volume":"33","author":"Matthias","year":"2015","journal-title":"Nat Biotechnol"},{"key":"49","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-biochem-060815-014556","article-title":"Mammalian Autophagy: How Does It Work?","volume":"85","author":"Rubinsztein","year":"2016","journal-title":"Ann Rev Biochem"},{"key":"50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.phrs.2016.01.028","article-title":"Pharmacological inhibitors of autophagy as novel cancer therapeutic agents","volume":"105","author":"Shen","year":"2016","journal-title":"Pharmacol Res"},{"key":"51","doi-asserted-by":"publisher","first-page":"17591","DOI":"10.18632\/oncotarget.7540","article-title":"The multifaceted role of autophagy in tumor evasion from immune surveillance","volume":"7","author":"Chouaib","year":"2016","journal-title":"Oncotarget"},{"issue":"107","key":"52","first-page":"300","article-title":"Microenvironment and autophagy cross-talk: Implications in cancer therapy","volume":"2016","author":"Menck","journal-title":"Pharmacol Res"},{"issue":"7","key":"53","first-page":"291","article-title":"Targeting autophagy in cancer management - strategies and developments","volume":"2015","author":"Benbrook","journal-title":"Cancer Manag Res"},{"issue":"34","key":"54","first-page":"856","article-title":"Autophagy in malignant transformation and cancer progression","volume":"2015","author":"Levine","journal-title":"EMBO J"},{"key":"55","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4161\/auto.6.3.11625","article-title":"Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer","volume":"6","author":"Ozpolat","year":"2010","journal-title":"Autophagy"},{"issue":"85","key":"56","first-page":"830","article-title":"Autophagy and cancer therapy","volume":"2014","author":"Gustafson","journal-title":"Mol Pharmacol"},{"key":"57","first-page":"599","article-title":"Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2 cells","volume":"27","author":"Ai","year":"2011","journal-title":"Int J Mol Med"},{"key":"58","first-page":"232","article-title":"Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells","volume":"314","author":"Sun","year":"2011","journal-title":"Cancer Lett"},{"key":"59","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1158\/1078-0432.CCR-10-0890","article-title":"Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy","volume":"17","author":"Chen","year":"2011","journal-title":"Clin Cancer Res"},{"key":"60","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1245\/s10434-008-0260-0","article-title":"Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells","volume":"16","author":"Kuwano","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"61","doi-asserted-by":"crossref","first-page":"e32584","DOI":"10.1371\/journal.pone.0032584","article-title":"Blocking autophagy prevents bortezomib-induced NF-kappaB activation by reducing I-kappaBalpha degradation in lymphoma cells","volume":"7","author":"Gribben","year":"2012","journal-title":"PLoS One"},{"key":"62","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4161\/auto.29165","article-title":"Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma","volume":"10","author":"Thamm","year":"2014","journal-title":"Autophagy"},{"key":"63","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1172\/JCI58530","article-title":"Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV","volume":"122","author":"Gao","year":"2012","journal-title":"J Clin Invest"},{"key":"64","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1128\/JVI.01098-15","article-title":"Screening of the human kinome identifies MSK1\/2-CREB1 as an essential pathway mediating Kaposi's sarcoma-associated herpesvirus lytic replication during primary infection","volume":"89","author":"Gao","year":"2015","journal-title":"J Virol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T16:46:59Z","timestamp":1589129219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,2,28]]}},"alternative-id":["14741","28118604"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14741","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]}}}